Brazikumab
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for Brazikumab, covering 2020-05-15 to 2026-06-23. Get the full timeline:
Most recent: Clinical Trial Results: Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis [Phase 2]